IP 3 -binding polypeptides and methods of using them

Details IP 3 -binding polypeptides and methods of using them IP 3 -binding polypeptides and methods of using them

2006-05-09

2006-05-09

Li, Ruixiang (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C514S012200, C530S350000

Reexamination Certificate

active

07041440

ABSTRACT:
The present invention provides a high affinity polypeptide having a binding activity to inositol 1,4,5-trisphosphate, to a gene encoding the polypeptide, to a recombinant vector including the gene, to a transformant including the vector and to a method for producing the high affinity polypeptide having a binding activity to inositol 1,4,5-trisphosphate.

REFERENCES:
patent: 2778771 (1991-08-01), None
patent: 08245698 (1996-09-01), None
patent: WO 96/00586 (1996-01-01), None
patent: WO96/24846 (1996-08-01), None
Verma et al., “Gene therapy—promises, problems, and prospects”. Nature, vol. 389 : 239-242, Sep. 1997.
Miller et al., “Targeted vectors for gene therapy.” FASEB Journal, vol. 9 : 190-199, Feb. 1995.
Blau et al., “Molecular Medicine, Gene therapy—A Novel Form of Drug Delivery”, The New England Journal of Medicine, vol.333 (18): 1204-1207, Nov. 1995.
Anderson FW, “Human gene therapy”. Nature, vol. 392 (SUPP): 25-30, Apr. 1998.
Frommel et al., “An estimate on the effect of point mutation and natural selection on the rate of amino acid replacement in proteins”, Journal of Molecular Evolution, vol. 21 : 233-257, 1985.
Ngo et al., “Computational Complexity, protein structure prediction, and the Levinthal Paradox”. The protein folding problem and tertiary structure prediction : 492-495, 1994.
Bowie et al., “Deciphering the message in protein sequences: tolerance to amino acid substitutions”. Science, vol. 247: 1306-1310, Mar. 1990.
Harnick et al., “The Human Type I Inositol 1, 4, 5-trisphosphate Receptor from T Lymphocytes”. Journal of Biol. Chem., vol. 270 (6): 2833-2840, Feb. 1995.
Furuichi et al., “Nucleotide Sequence of cDNA encoding P400 protein in the mouse cerebellum”, Nucleic Acid Res., vol. 17 (13): 5385-5386,1989.
Mignery et al., “Structure and Expression of the Rat Inositol 1, 4, 5-trisphosphate Receptor”. Journal of Biol. Chem., vol. 265 (21): 12679-12685, Sep. 1997.
Yamada et al., “Human Inositol 1, 4, 5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization”. Biochem. J., vol. 302 : 781-790, 1994.
Yoshikawa et al.; High Efficient Expression of the Functional Ligand Binding Site of the Inositol 1,4,5-Trisphosphate Receptor inEscherichia coli, 1999 Biochemical and Biophysical Research Comm.: 792-797.
Newton et al.; Co-expression in Vertebrate Tissues and Cell Lines of Multiple Inositol 1,4,5-Trisphosphate (InsP) Receptors with Distinct Affinities for InsP, 1994, The Journal of Biological Chemistry, vol. 269,No. 46:28613-28619.
Crystal R., “Transfer of genes to humans: Early lessons and obstacles to success.” Science, vol. 270: 404-410, 1995.
Deonarian M., “Ligand-targeted receptor-mediated vectors for gene delivery.” Exp. Opin. Ther. Patents, vol. 8 (1):53-69, 1998.
Eck et al., “Gene-based therapy.” Goodman & Gilman's The Pharmacological Basis of Therapeutics—Ninth Edition, McGraw-Hill: 77-101, 1996.
Mignery et al., “Structure and Expression of the Rat Inositol 1,4,5-Trisphosphate Receptor,” J. Biol. Chem. vol. 265, No. 21, pp. 12679-12685 (1990).
Furuichi et al., Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400.Nature, 342:32-38, Nov. 2, 1989 (XP-002141737).
Yoshikawa, et al., “Mutational Analysis of the Ligand Binding site of the Inositol 1,4,5-Trisphosphate Receptor”, The Journal of Biological Chemistry, vol. 271, No. 30, pp. 18277-18284, Jul. 26, 1996.

Affiliated with

Also associated with

Rating

IP 3 -binding polypeptides and methods of using them does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with IP 3 -binding polypeptides and methods of using them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IP 3 -binding polypeptides and methods of using them will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569410